Skip to content
Study details
Enrolling now

A Study of Pulmonary Hypertension Peripheral Limitations

Mayo Clinic
NCT IDNCT05968859ClinicalTrials.gov data as of Apr 2026
Target enrollment

45

Study length

about 4.2 years

Ages

18+

Locations

1 site in MN

About this study

Researchers are testing whether aerobic training or leg training improves symptoms and quality of life in people with pulmonary arterial hypertension (PAH). The trial will last for 1550 days.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in Aerobic Training
  • 2.Participate in Leg Training

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low14%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Secondary: Change in Quality of Life as measured by the 36-Item Short-Form Survey (SF-36), Change in Quality of Life as measured by the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) questionnaire, Change in Quality of Life as measured by the emPHasis-10 questionnaire

Body systems

Respiratory